Association between influenza vaccination and reduced risks of major adverse cardiovascular events in elderly patients

American Heart Journal

Volumn 193, Issue , 2017, Pages 1-7

  Chiang, Ming Hsien ^a   Wu, Hau Hsin ^b   Shih, Chia Jen ^c   Chen, Yung Tai ^c,d   Kuo, Shu Chen ^c,e   Chen, Te Li ^a,c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CENTER FOR DISEASE CONTROL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FLU LIKE SYNDROME; HEART INFARCTION; HEART PROTECTION; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; AGE; FOLLOW UP; INCIDENCE; INFLUENZA; ODDS RATIO; TAIWAN; VACCINATION;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; TAIWAN; VACCINATION;

EID: 85028465130     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2017.07.020     Document Type: Article

References (38)

1. Lopez, A.D., Mathers, C.D., Ezzati, M., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:9524 (2006), 1747–1757.
2. Straus, S.E., Majumdar, S.R., McAlister, F.A., New evidence for stroke prevention: scientific review. JAMA 288:11 (2002), 1388–1395.
3. Wong, N.D., Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol 11:5 (2014), 276–289.
4. Arcari, C.M., Gaydos, C.A., Nieto, F.J., et al. Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement. Clin Infect Dis 40:8 (2005), 1123–1130.
5. Warren-Gash, C., Smeeth, L., Hayward, A.C., Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9:10 (2009), 601–610.
6. Bova, I.Y., Bornstein, N.M., Korczyn, A.D., Acute infection as a risk factor for ischemic stroke. Stroke 27:12 (1996), 2204–2206.
7. Lavallée, P., Perchaud, V., Gautier-Bertrand, M., et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 33:2 (2002), 513–518.
8. Siriwardena, A.N., Gwini, S.M., Coupland, C.A., Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 182:15 (2010), 1617–1623.
9. Pinol-Ripoll, G., de la Puerta, I., Santos, S., et al. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. Cerebrovasc Dis 26:4 (2008), 339–347.
10. Lavallee, P.C., Labreuche, J., Fox, K.M., et al. Influenza vaccination and cardiovascular risk in patients with recent TIA and stroke. Neurology 82:21 (2014), 1905–1913.
11. Van Ermen, A., Hermanson, M.P., Moran, J.M., et al. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 15:5 (2013), 560–564.
12. VanWormer, J.J., Sundaram, M.E., Meece, J.K., et al. A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting. BMC Infect Dis, 14, 2014, 231.
13. Deiss, R.G., Arnold, J.C., Chen, W.J., et al. Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease. Vaccine 33:51 (2015), 7160–7167.
14. Casado, I., Dominguez, A., Toledo, D., et al. Effect of influenza vaccination on the prognosis of hospitalized influenza patients. Expert Rev Vaccines 15:3 (2016), 425–432.
15. Chiu, P.J., Chen, C.H., Chih, Y.C., Effectiveness of the influenza vaccination program for the elderly in Taiwan. Vaccine 31:4 (2013), 632–638.
16. Wu, T.Y., Majeed, A., Kuo, K.N., An overview of the healthcare system in Taiwan. London J Prim Care (Abingdon) 3:2 (2010), 115–119.
17. Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:6 (1992), 613–619.
18. Wu, H.H., Chen, Y.T., Shih, C.J., et al. Association between recent use of proton pump inhibitors and nontyphoid salmonellosis: a nested case-control study. Clin Infect Dis 59:11 (2014), 1554–1558.
19. Charlson, M.E., Pompei, P., Ales, K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:5 (1987), 373–383.
20. Goldstein, L.B., Bushnell, C.D., Adams, R.J., et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:2 (2011), 517–584.
21. Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:25 Suppl. 2 (2014), S49–73.
22. Corrales-Medina, V.F., Madjid, M., Musher, D.M., Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 10:2 (2010), 83–92.
23. Corrales-Medina, V.F., Musher, D.M., Shachkina, S., et al. Acute pneumonia and the cardiovascular system. Lancet 381:9865 (2013), 496–505.
24. Stokes, K.Y., Granger, D.N., Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol 590:5 (2012), 1023–1034.
25. Schouten, M., Wiersinga, W.J., Levi, M., et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:3 (2008), 536–545.
26. Milbrandt, E.B., Reade, M.C., Lee, M., et al. Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Mol Med 15:11–12 (2009), 438–445.
27. Vallance, P., Collier, J., Bhagat, K., Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?. Lancet 349:9062 (1997), 1391–1392.
28. Yang, Y., Tang, H., Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol 13:4 (2016), 432–442.
29. Clar, C., Oseni, Z., Flowers, N., et al. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev, 5, 2015, CD005050.
30. Udell, J.A., Zawi, R., Bhatt, D.L., et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:16 (2013), 1711–1720.
31. Bermudez-Fajardo, A., Oviedo-Orta, E., Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis 217:1 (2011), 97–105.
32. Binder, C.J., Horkko, S., Dewan, A., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:6 (2003), 736–743.
33. Yende, S., D'Angelo, G., Kellum, J.A., et al. Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 177:11 (2008), 1242–1247.
34. Jian, Y.R., Chang, S.Y., Lin, P.Y., et al. Inactivated influenza virus vaccine is efficient and reduces IL-4 and IL-6 in allergic asthma mice. Influenza Other Respi Viruses 7:6 (2013), 1210–1217.
35. Gilca, R., Amini, R., Douville-Fradet, M., et al. Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season. Open Forum Infect Dis, 1(2), 2014, ofu086.
36. Nichol, K.L., D'Heilly, S.J., Greenberg, M.E., et al. Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. Clin Infect Dis 48:3 (2009), 292–298.
37. Jackson, L.A., Nelson, J.C., Benson, P., et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35:2 (2006), 345–352.
38. Simonsen, L., Taylor, R.J., Viboud, C., et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7:10 (2007), 658–666.